PC-SPES: herbal formulation for prostate cancer (Q34914418)

5 August 2017

1 reference

title

PC-SPES: herbal formulation for prostate cancer (English)

1 reference

5 August 2017

1 reference

4

Sophie Chen

0 references

Franklin C. Lowe

7

object named as

Franklin C Lowe

1 reference

5 August 2017

Leonard S Marks

1

1 reference

5 August 2017

Robert S DiPaola

2

1 reference

5 August 2017

Peter Nelson

3

1 reference

5 August 2017

David Heber

5

1 reference

5 August 2017

Arie S Belldegrun

6

1 reference

5 August 2017

John Fan

8

1 reference

5 August 2017

Floyd E Leaders

9

1 reference

5 August 2017

Allan J Pantuck

10

1 reference

5 August 2017

Varro E Tyler

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

5 August 2017

1 reference

5 August 2017

60

1 reference

5 August 2017

3

1 reference

5 August 2017

369-75; discussion 376-7

1 reference

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

The importance of using scientific principles in the development of medicinal agents from plants

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Chelation therapy in children exposed to lead

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Cell death induced by baicalein in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Molecular mechanism of inhibition of steroid dehydrogenases by licorice-derived steroid analogs in modulation of steroid receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

In vitro mechanism of PC SPES.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

PC-SPES and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Anti-inflammatory properties and inhibition of leukotriene C4 biosynthesis in vitro by flavonoid baicalein from Scutellaria baicalensis georgy roots

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

PC-SPES: current evidence and remaining questions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901913-1

7 January 2021

10.1016/S0090-4295(02)01913-1

Identifiers

DOI

1 reference

5 August 2017

1 reference